Fiduciary Family Office’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,310
Closed -$367K 183
2026
Q1
$367K Buy
4,310
+409
+10% +$36.5K 0.1% 138
2025
Q4
$308K Sell
3,901
-8,556
-69% -$671K 0.09% 139
2025
Q3
$996K Buy
12,457
+3,382
+37% +$288K 0.28% 69
2025
Q2
$825K Buy
9,075
+195
+2% +$17.8K 0.27% 72
2025
Q1
$832K Buy
+8,880
New +$795K 0.28% 77
2024
Q4
Sell
-6,780
Closed -$704K 111
2024
Q3
$704K Buy
+6,780
New +$691K 0.23% 93

Other funds holding CL

Fiduciary Family Office's CL Position: Q2 2026 in Review

Fiduciary Family Office sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 4,310 shares — an estimated $367K sold.

Fiduciary Family Office first reported a position in CL in Q3 2024 and held it in 6 quarters. The position peaked at $996K in Q3 2025. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Fiduciary Family Office reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Fiduciary Family Office sold 4,310 Colgate-Palmolive shares in Q2 2026, an estimated $367K.
  • Fiduciary Family Office first reported a position in Colgate-Palmolive in Q3 2024 and held it in 6 quarters.
  • Fiduciary Family Office's Colgate-Palmolive position peaked at $996K in Q3 2025.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.